TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Ohio Investigators

Mark Knapp, M.D.

Zangmeister Center/Mid Ohio Oncology Hematology


Columbus, Ohio - 43219 (614-383-6686)
  • CLINICAL TRIALS 1
  • CONDITIONS3
  • INTERVENTIONS2
  • SINCE2009
Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

July 2009 - May 2016
Lymphoma

Lymphoma, B-Cell

Lymphoma, Large B-Cell, Diffuse

Placebo

Rad001

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo